Drug Type Small molecule drug |
Synonyms MTB 9655, MTB-9655 |
Target |
Mechanism ACSS2 inhibitors(Acetyl-coenzyme A synthetase, cytoplasmic inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Metabomed Ltd.Startup |
Active Organization- |
Inactive Organization Metabomed Ltd.Startup |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Locally Advanced Malignant Solid Neoplasm | Phase 1 | US | - | 30 Jun 2021 |
Locally Advanced Malignant Solid Neoplasm | Phase 1 | IL | - | 30 Jun 2021 |
Solid tumor | Phase 1 | IL | Metabomed Ltd.Startup | 11 Jun 2021 |
Phase 1 | 10 | shcwpbzwia(zrndbwvouc) = unycpqsqpy urycgillfl (tfmvbffgvq ) View more | - | 02 Jun 2022 |